USFDA completes inspection at facility of Granules India’s arm

20 Jan 2020 Evaluate

US Food and Drug Administration (USFDA) has completed inspection of the facility of Granules India’s wholly owned foreign subsidiary -- Granules Pharmaceuticals, Inc., on January 17, 2020 with three minor observations. This is a pre-approval inspection for a product filed from this facility. Granules Pharmaceuticals, Inc. will respond to these observations within the stipulated time period.

Granules India is manufacturer and supplier of pharmaceutical products. Its products include active pharmaceutical ingredients (API) like tablets, caplets, rapid release, pharmaceutical, formulation intermediates (PFI) and Finished Dosages (FDs).

Granules India Share Price

604.80 -1.10 (-0.18%)
10-Jan-2025 09:17 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1826.90
Dr. Reddys Lab 1374.55
Cipla 1488.10
Lupin 2252.35
Zydus Lifesciences 1006.65
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.